Calendrier des promotions Guardant Health, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise
Guardant Health, Inc., компания, специализирующаяся на точной онкологии, предоставляет анализы крови, наборы данных и аналитику в США и за рубежом. Компания предлагает тесты жидкой биопсии для рака поздней стадии, такие как Guardant360, молекулярный диагностический тест, который измеряет различные гены, связанные с раком; и GuardantOMNI, более широкая панель генов, включающая гены, связанные с дефицитом восстановления гомологичной рекомбинации, и биомаркеры для иммуноонкологических приложений. plus de détails| IPO date | 2018-10-04 |
|---|---|
| ISIN | US40131M1099 |
| Industry | Health Care Providers & Services |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://guardanthealth.com |
| Цена ао | 36.71 |
| Changement de prix par jour: | -2.86% (48.6) |
|---|---|
| Changement de prix par semaine: | +28.78% (36.66) |
| Changement de prix par mois: | +49.54% (31.57) |
| Changement de prix sur 3 mois: | +130.18% (20.51) |
| Changement de prix sur six mois: | +30.09% (36.29) |
| Changement de prix par an: | +104.37% (23.1) |
| Evolution du prix sur 3 ans: | -35.28% (72.94) |
| Evolution du prix sur 5 ans: | -39.58% (78.13) |
| Evolution des prix sur 10 ans: | 0% (47.21) |
| Evolution des prix depuis le début de l'année: | +50.49% (31.37) |
|
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
|||||||||||||||||||||||||||||||||||||
| Date de transaction | Date de divulgation | Insider | Taper | Prix | Volume | Quantité | Partagez jusqu'à, % | Partager après, % | Document |
|---|---|---|---|---|---|---|---|---|---|
| 04.01.2025 | 06.01.2025 | Joyce Meghan V. Director |
Achat | 35.88 | 2 368 | 66 | 0 | 0 | lien |
| 01.01.2025 | 03.01.2025 | Saia John G. Chief Legal Officer |
Achat | 33.76 | 89 160 | 2641 | 0 | 0 | lien |
| 18.12.2024 | 19.12.2024 | Tariq Musa Director |
Vente | 34.85 | 4 043 | 116 | 0 | 0 | lien |
| 15.12.2024 | 16.12.2024 | Tariq Musa Director |
Achat | 35.62 | 8 905 | 250 | 0 | 0 | lien |
| 15.12.2024 | 16.12.2024 | Bell Michael Brian Chief Financial Officer |
Achat | 35.62 | 116 549 | 3272 | 0 | 0 | lien |
| 15.12.2024 | 16.12.2024 | EAGLE CRAIG Chief Medical Officer |
Achat | 35.62 | 49 939 | 1402 | 0 | 0 | lien |
| 15.12.2024 | 16.12.2024 | Freeman Chris Chief Commercial Officer |
Achat | 35.62 | 49 939 | 1402 | 0 | 0 | lien |
| 15.12.2024 | 16.12.2024 | Kalia Kumud Chief Information Officer |
Achat | 35.62 | 22 690 | 637 | 0 | 0 | lien |
| 15.12.2024 | 16.12.2024 | POTTER MYRTLE S Director |
Achat | 35.62 | 2 458 | 69 | 0 | 0 | lien |
| 15.12.2024 | 16.12.2024 | Saia John G. Chief Legal Officer |
Achat | 35.62 | 36 332 | 1020 | 0 | 0 | lien |
| 13.12.2024 | 16.12.2024 | Tariq Musa Director |
Vente | 35 | 81 200 | 2320 | 0 | 0 | lien |
| 04.12.2024 | 05.12.2024 | Joyce Meghan V. Director |
Achat | 35.52 | 2 380 | 67 | 0 | 0 | lien |
| 04.10.2024 | 07.10.2024 | Joyce Meghan V. Director |
Achat | 21.35 | 1 409 | 66 | 0 | 0 | lien |
| 04.07.2024 | 08.07.2024 | Joyce Meghan V. Director |
Achat | 27.57 | 1 820 | 66 | 0 | 0 | lien |
| 31.03.2024 | 01.04.2024 | Eltoukhy Helmy Co-Chief Executive Officer |
Achat | 20.25 | 232 085 | 11461 | 0 | 0.01 | lien |
| 31.03.2024 | 01.04.2024 | Talasaz AmirAli Co-Chief Executive Officer |
Achat | 20.25 | 232 085 | 11461 | 0 | 0.01 | lien |
| 04.03.2024 | 05.03.2024 | Joyce Meghan V. Director |
Vente | 19.05 | 1 905 | 100 | 0 | 0 | lien |
| 04.03.2024 | 05.03.2024 | Joyce Meghan V. Director |
Achat | 18.73 | 1 236 | 66 | 0 | 0 | lien |
| 01.12.2023 | 04.12.2023 | Chudova Darya Chief Technology Officer |
Achat | 26.95 | 8 489 | 315 | 0 | 0 | lien |
| 01.12.2023 | 04.12.2023 | Kalia Kumud Chief Information Officer |
Vente | 26.37 | 152 946 | 5800 | 0 | -0.01 | lien |
| 01.12.2023 | 04.12.2023 | Kalia Kumud Chief Information Officer |
Achat | 26.95 | 19 135 | 710 | 0 | 0 | lien |
| 01.12.2023 | 04.12.2023 | Merrill Amelia SVP, People |
Achat | 26.95 | 4 258 | 158 | 0 | 0 | lien |
| 01.12.2023 | 04.12.2023 | Saia John G. Chief Legal Officer |
Achat | 26.95 | 7 088 | 263 | 0 | 0 | lien |
| 30.11.2023 | 04.12.2023 | Krognes Steve E. Director |
Achat | 26.95 | 4 150 | 154 | 0 | 0 | lien |
| 15.09.2023 | 19.09.2023 | Bell Michael Brian Chief Financial Officer |
Achat | 32.38 | 39 925 | 1233 | 0 | 0 | lien |
| 15.09.2023 | 19.09.2023 | POTTER MYRTLE S Director |
Achat | 32.38 | 2 234 | 69 | 0 | 0 | lien |
| 12.09.2023 | 13.09.2023 | Kalia Kumud Chief Information Officer |
Vente | 32.59 | 69 254 | 2125 | 0 | 0 | lien |
| 15.01.2023 | 17.01.2023 | POTTER MYRTLE S Director |
Achat | 31.12 | 2 116 | 68 | 0 | 0 | lien |
| 15.01.2023 | 17.01.2023 | Bell Michael Brian CHIEF FINANCIAL OFFICER |
Achat | 31.12 | 102 976 | 3309 | 0 | 0 | lien |
| 04.01.2023 | 05.01.2023 | Joyce Meghan V. Director |
Achat | 27.32 | 1 830 | 67 | 0 | 0 | lien |
| 13.08.2021 | 17.08.2021 | Eltoukhy Helmy Co-Chief Executive Officer |
Achat | 4.18 | 99 998 | 23923 | 0 | 0.02 | lien |
| 13.08.2021 | 17.08.2021 | Talasaz AmirAli Co-Chief Executive Officer |
Achat | 4.18 | 99 998 | 23923 | 0 | 0.02 | lien |
| 19.04.2021 | 19.04.2021 | Eltoukhy Helmy Chief Executive Officer |
Vente | 152.97 | 7 791 070 | 50932 | 0 | -0.05 | lien |
| 16.04.2021 | 19.04.2021 | Eltoukhy Helmy Chief Executive Officer |
Vente | 158.34 | 8 094 820 | 51123 | 0 | -0.05 | lien |
| 15.04.2021 | 19.04.2021 | Eltoukhy Helmy Chief Executive Officer |
Vente | 158.85 | 24 956 400 | 157107 | 0 | -0.17 | lien |
| 11.02.2021 | 12.02.2021 | Talasaz AmirAli Chairman, President and COO |
Vente | 166.56 | 3 918 990 | 23529 | 0 | -0.03 | lien |
| 11.02.2021 | 12.02.2021 | Talasaz AmirAli Chairman, President and COO |
Vente | 166.98 | 33 771 900 | 202251 | 0 | -0.22 | lien |
| 10.02.2021 | 12.02.2021 | Talasaz AmirAli Chairman, President and COO |
Vente | 160.9 | 1 398 060 | 8689 | 0 | -0.01 | lien |
| 10.02.2021 | 12.02.2021 | Talasaz AmirAli Chairman, President and COO |
Vente | 160.9 | 9 381 110 | 58304 | 0 | -0.06 | lien |
| Établissements | Volume | Partager, % |
|---|---|---|
| Vanguard Group Inc | 11130654 | 9.15 |
| Blackrock Inc. | 10831716 | 8.9 |
| Baillie Gifford and Company | 6178812 | 5.08 |
| FMR, LLC | 5251349 | 4.31 |
| Deep Track Capital, LP | 5000000 | 4.11 |
| Capital International Investors | 4001803 | 3.29 |
| Eventide Asset Management LLC | 3888146 | 3.19 |
| AllianceBernstein L.P. | 3708283 | 3.05 |
| Temasek Holdings (Private) Limited | 3673243 | 3.02 |
| Parkwood LLC | 2800000 | 2.3 |
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
|---|---|---|---|
| Dr. Helmy Eltoukhy Ph.D. | Co-Founder, Co-CEO & Chairman | 11.63k | 1979 (46 années) |
| Mr. John G. Saia | Chief Legal Officer & Corporate Secretary | 627.18k | 1973 (52 année) |
| Mr. Michael Bell | Chief Financial Officer | 630.99k | 1969 (56 années) |
| Mr. Kumud Kalia | Chief Information Officer | N/A | 1966 (59 années) |
| Dr. AmirAli Talasaz Ph.D. | Co-CEO & Director | 11.18k | 1980 (45 années) |
| Ms. Jennifer Higgins | Senior Vice President of Public Affairs | N/A | |
| Dr. Craig Eagle M.D. | Chief Medical Officer | 649.13k | 1967 (58 années) |
| Mr. Christopher Freeman | Chief Commercial Officer | 630.39k | 1974 (51 année) |
| Ms. Darya Chudova | Chief Technology Officer | N/A | 1974 (51 année) |
| Zarak Khurshid | Vice President of Investor Relations |
Adresse: United States, Redwood City, CA , 505 Penobscot Drive - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: http://guardanthealth.com
Site web: http://guardanthealth.com
